MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Faculty

David Agus, M.D.
Project Leader: Project 4
Associate Professor of Medicine
Cedars-Sinai Medical Center
Director, Louis Warschaw Prostate Cancer Center
8631 West Third Street, Suite 215E
Los Angeles, CA 90048
Phone: (310) 423-7600
Fax: (310) 423-1998
Email: david.agus@cshs.org


Project Leader: Project 4, Associate Professor of Medicine (Cedars-Sinai; UCLA)
Consultant for Cancer Biology/Oncology Expertise for Project 5

Dr. Agus is Research Director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai Medical Center and an internationally recognized investigator in the field of genitourinary cancers. Under the leadership of Dr. Agus, the Prostate Cancer Center's research team is focusing on the factors influencing the development and progression of prostate cancer. In the laboratory, Dr. Agus is conducting research focused on understanding the biology of cancer and the development of new therapeutics for prostate cancer. His laboratory has made important contributions regarding the Her-kinase axis and related therapeutics. He is also Director of the Spielberg Proteomics Center at Cedars-Sinai that is developing technologies to better understand clinical outcomes and ultimately a more complete understanding of the various factors that influence cancer development, progression and response to treatment. Dr. Agus is leading the clinical trials programs of the Prostate Cancer Center.

[ Back ]
crumpnews events